Mucosal healing in inflammatory bowel disease.


It is becoming increasingly recognized that purely clinical endpoints may not be sufficient in the treatment of patients with inflammatory bowel disease. As such, mucosal disease assessment has become a prominent component of the majority of recent clinical trials in Crohn's disease and ulcerative colitis. There is mounting evidence that the attainment of… (More)
DOI: 10.1097/MCG.0b013e3182732ff5


3 Figures and Tables